Cooley M&A

JUNE 10, 2020

On May 27th, Andy Pasternak, Executive Vice President, Chief Strategy Officer at Horizon Therapeutics and Eric Tokat, a partner in the healthcare practice at Centerview Partners joined Cooley M&A co-chair, Barbara Borden for a discussion of the life sciences M&A market, with a focus on business development. Credibility is key.

M&A 40

M&A Medical Acquisitions Business 40

How2Exit

OCTOBER 7, 2024

E247: Why Accurate Financials are Key to Success in Buying, Selling, and Valuing Businesses - Watch Here About the Guest(s): Ryan Hutchins is an accomplished entrepreneur and expert in the field of mergers and acquisitions. With a background in finance and accounting from his time at Deloitte, Ryan has built his expertise in business valuation.

Business 130

Business Mergers and Acquisitions Valuation Acquisitions 130

Cooley M&A

JANUARY 24, 2020

Detailed below are our “notes from the field” for tech M&A in 2019. Tech M&A hit the global regulatory crosshairs in 2019 – creating a deal environment in which regulatory clearance, timing and scope of review quickly become one of the most critical factors in assessing transaction risk.

M&A 40

M&A Mergers and Acquisitions Mergers Business 40

Cooley M&A

JANUARY 25, 2023

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

OfficeHours

JULY 18, 2023

In this industry, owning 50 to 100 or more veterinary centers gives you procurement advantages in that you can buy much higher volumes of suppliers (syringes, medical equipment, etc.) As it happens, this is an industry that has experienced a significant amount of private equity-backed roll-up activity.

Private Equity 130

Private Equity Equities Investment Mergers and Acquisitions 130

How2Exit

MAY 9, 2023

Once the financials and legal aspects are understood, it is important to negotiate the terms of the purchase. Concept 2: DSOs and MSOs Buy Practices One of the topics discussed on the How to Exit podcast is the purchase of dental and medical practices by Dental Service Organizations (DSOs) and Medical Service Organizations (MSOs).

Business 130

Business Investment IT Economics 130

Focus Investment Banking

JUNE 13, 2023

Compared to other medical fields like dentistry and dermatology, private equity involvement in orthopedic practices has been relatively small. Despite the recent rash of M&A deals, the orthopedic business, like other medical fields, remains highly fragmented.

Private Equity 52

Private Equity Equities Healthcare Medical 52

Lake Country Advisors

MARCH 22, 2024

International mergers and acquisitions (M&A) offer the potential for rapid market expansion, access to cutting-edge technologies, and significant cost savings. In today’s interconnected global marketplace, businesses in Wisconsin and Illinois are increasingly looking beyond domestic borders for growth opportunities.

Mergers and Acquisitions 52

Mergers and Acquisitions Mergers Acquisitions Healthcare 52

Cooley M&A

OCTOBER 24, 2024

While this mantra may help bruised egos on the playground, it’s of no use in M&A disputes. September 2024), the Delaware Chancery Courts found buyers liable for failure to comply with negotiated earnout covenants – and in the latter case, awarded the plaintiffs more than $1 billion in damages. On the other hand, in Fortis v.

Mergers and Acquisitions 52

Mergers and Acquisitions Mergers Negotiation Sale 52

Lake Country Advisors

OCTOBER 17, 2024

Their primary role is to manage the complexities of the sale, including identifying potential buyers, valuing the business, and negotiating terms. This saves time and prevents distractions during negotiations. If you’re considering buying or selling a business, you’ve likely come across the term “business broker.”

Broker 52

Broker Business Sale Negotiation 52

Cooley M&A

JULY 10, 2017

In life sciences/medical technology transactions, buyers and sellers often use milestone-based and sometimes royalty-based contingent consideration to compensate sellers for assets that are in various stages of development from clinical- to development-stage to product commercialization. [1] Private placement.

Securities 52

Securities IT Investors M&A 52

How2Exit

MARCH 2, 2023

He tried a medical website, local portals, computer networking, and websites. Ron Concept 1: Set Your Own Agenda Scotty's story also highlights the importance of setting your own agenda. In business, you have to make your own season and create your own agenda. It's also important to remember that you don't have to do it alone.

Business 130

Business Book-building Sale IT 130

The Deal

OCTOBER 2, 2023

Nonsan, South Korea-based Routejade makes graphite-based lithium-ion batteries for consumer electronics such as wearable technology, as well as in medical, industrial military applications. Lithium-ion battery maker Enovix Corp. said Wednesday, Sept. 20, it has acquired Korean battery component manufacturer Routejade Inc. Fremont, Calif.-based

Manufacturing 69

Manufacturing Electronics IT Investors 69

Software Equity Group

MARCH 26, 2024

RELATED BLOG ARTICLE : Strategic vs. Financial Buyers: A Look at The Top Differences During M&A Francisco Partners Founded in 1999 and based in the tech hub of San Francisco, Francisco Partners provides flexible capital and partnerships to “growth-aspiring technology companies.” The firm employs 93 professionals.

Private Equity 52

Private Equity Equities Investment Portfolio 52

Peak Frameworks

SEPTEMBER 19, 2023

The distinction between them is crucial for understanding a company's obligations, its strategy, and the interplay of interests within its ecosystem. What is a Shareholder? A shareholder is an individual or entity that owns shares or stock in a corporation. Shareholders: are primarily concerned about financial returns.

Corporation 52

Corporation Private Equity Mergers and Acquisitions Corporate Finance 52

Lake Country Advisors

SEPTEMBER 30, 2024

Buying an existing business can be a smart move, offering the benefits of an established operation. However, it also comes with its own set of challenges, especially regarding legal and financial complexities. Conducting thorough due diligence is crucial to uncover hidden issues, such as undisclosed debts or potential legal disputes.

Business 52

Business Valuation Financial Statement Broker 52

Cooley M&A

JANUARY 20, 2022

General trends in life sciences M&A. While 2020’s M&A landscape was characterized by whiplash volatility from choppy deal activity in the first half of the year to a surge in volume in the second half, that momentum accelerated in 2021, with no signs of slowing down heading into 2022. driven assets.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

JANUARY 25, 2023

Tech M&A in 2022 was a tale of two halves. 2] Despite the downtrend, global tech M&A activity in 2022 remained strong relative to pre-pandemic levels and accounted for a record 20% of all global M&A activity. Deal volumes dropped from $531.13 billion [1] during the first half of 2022 to $189.17 trillion. [2]

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Cleary M&A and Corporate Governance Watch

MARCH 29, 2023

However, we expect that there will be lots of negotiating over the fiscal 2024 budget, so one or more of these proposals may find their way into the final budget. We will publish updates as these proposals evolve. The tax for the initial year would be paid over nine years, and over five years for subsequent years.

Accountant 52

Accountant Medical Investment Funds 52

Cooley M&A

JANUARY 25, 2024

Cross-border M&A activity in 2023 was impacted by heightened geopolitical conflicts, high inflation and interest rates, and increased regulatory pressures as the global economy remained clouded by looming recession fears. The aggressive rate hikes contributed to the decline in M&A activity in 2023. trillion and $4.09

M&A 52

M&A Mergers and Acquisitions Investment Government 52